Michael Sullivan

Chief Financial Officer & Interim Principal Executive Officer

Mr. Sullivan is serving as our Interim Principal Executive Officer. Mr. Sullivan previously served as our Interim Principal Executive Officer from October 30, 2014 until June 5, 2016. Mr. Sullivan is serving as our Chief Financial Officer, Secretary and Treasurer since February 6, 2012. Mr. Sullivan has held senior level financial positions for several publicly and privately held businesses including Utek Corporation, eANGLER, and HSN Direct International Limited. Most recently, he was the Group Financial Officer for the Investigative Services and Litigation Consulting Services segment of First Advantage Corporation a firm specializing in talent acquisition solutions where he streamlined the employee recruitment process. Mr. Sullivan is a Florida Certified Public Accountant. He graduated from the Florida State University with a Bachelor of Science in Accounting and a Master of Business Administration.

Martin (Marty) Handfield, PhD

Senior Vice President of Discovery Research

Dr. Martin (Marty) Handfield is Oragenics’ Senior Vice President of Discovery Research and has previously served as our Director of Research and Development. Prior to joining the company in 2009, Dr. Handfield held a position as Tenured Associate Professor at the Center for Molecular Microbiology and the Department of Oral Biology at the University of Florida College of Dentistry, where he co-invented IVIAT and co-founded IVI Gene Corporation and Epicure Corporation. 

Dr. Handfield holds a B.S. in Biochemistry and an M.S. and PhD in Microbiology and Immunology from the Université Laval College of Medicine in Canada. He completed postdoctoral training at the University of Florida.